CSIMarket
 
Orgenesis Inc.  (ORGS)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

Orgenesis Growth Comparisons

Select each growth Category to receive further Information



ORGS Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 128.77 % 5.69 % 5.16 % 7.4 %
Q / Q Revenue Growth (Q3 MRQ) 17.58 % 1.98 % 0.94 % 0.72 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 130.14 % 3.34 % 7.91 % %
Seq. Revenue Growth (for 12 months ending Q3 TTM) 21.59 % 1.42 % 1.17 % 1.56 %
Revenue 5 Year Average Growth - 12 % 10.84 % 8.61 %
Expected Revenue Growth (Y/Y) - - 1.89 % 3.04 %


ORGS's Growth Comparisons in III. Quarter 2019




Impressive surge in Orgenesis's Revenue in the third quarter 2019 by 128.77% from the same quarter a year ago, to 9 millions, appears to be a slow-down from Orgenesis's growth trends, but competes favorably to the 5.69% growth in Biotechnology & Drugs industry, and 5.16% growth in the Healthcare sector. Despite modest Sales rises in Healthcare sector and Biotechnology & Drugs industry, Orgenesis Inc. reported above average market Sales growth.

Top-line improved by 17.58% from the second quarter. Looking into annual sales rise of %, and S & P 500's average yearly sales growth is 8.61% over the five years, including only Businesses with the third quarter 2019 Results. Orgenesis grew less than the market.


Growth Rates of ORGS's Income in the third quarter 2019


ORGS Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) 60.09 % - 52.54 % 23.17 %
Seq. Operating Income Change (Q3 MRQ) -15.78 % - -21.76 % -15.62 %
Y / Y Operating Income Growth (Q3 TTM) -0.15 % - -47.91 % -7.34 %
Seq. Operating Income Growth (Q3 TTM) 9.97 % - 36.31 % 1.52 %
Operating Income 5 Year Avg. Change - -3.76 % 1.51 % 12.61 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) 98.47 % - -44.88 % -8.23 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) -15.64 % - -50.6 % -10.55 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) -23.89 % - 120.11 % 14.49 %
Seq. Income from Cont. Ops. Change (Q3 TTM) 12.53 % - -11.14 % -1.27 %
Income from Cont. Ops. 5 Year Avg. Change 28.1 % -6.15 % 7.91 % 32.82 %

ORGS Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) 98.47 % - -45.67 % -11.36 %
Q / Q Net Income Growth (Q3 MRQ) -15.64 % - -51.01 % -14.39 %
Y / Y Net Income Change (Q3 TTM) -23.89 % - 135.14 % 14.34 %
Seq. Net Income Change (Q3 TTM) 12.53 % - -11.41 % -1.36 %
Net Income 5 Year Avg. Growth 28.1 % -5.2 % 1.82 % 32.13 %

ORGS's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) 120 % - -44.88 % -8.23 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) 22.22 % - -50.6 % -10.55 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) 11.14 % - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) 44.6 % - - -4.96 %
EPS from Cont. Ops. 5 Year Avg. Growth 67.03 % -16.23 % 7.91 % 32.82 %



ORGS EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) 120 % - -45.67 % -11.36 %
Q / Q EPS Net Growth (Q3 MRQ) 22.22 % - -51.01 % -14.39 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 65.87 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) 44.6 % - - -2.08 %
EPS Net 5 Year Avg. Change 67.03 % -5.2 % 1.82 % 32.13 %
Expected EPS Growth (Y/Y) - - 123.59 % 31.27 %



Impressive surge in Orgenesis's EPS in the third quarter by 120% from the same quarter a year ago, to $0.44 , appears to be a slow-down from Orgenesis's growth trends, but competes favorably to the 5.69% growth in Biotechnology & Drugs industry, and -45.67% drop in the Healthcare sector. Comparing third quarter income per share growth, both Biotechnology & Drugs industry and Orgenesis Inc. outperformed -11.36% overall market increase.

Company's sequential bottom-line increase was 22.22% from the second quarter. Average annual income per share rise for Orgenesis is 67.03%, while S & P 500's average yearly income per share growth is 32.13% over the five years, including only Businesses with the third quarter 2019 earnings results.

ORGS Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - 52.2 % 18.1 % -20.41 %
Seq. Free Cash Flow Change (Q3 MRQ) - 178742.09 % 106.22 % 7.81 %
Y / Y Free Cash Flow Change (Q3 TTM) - -16.5 % -0.56 % -8.89 %
Seq. Free Cash Flow Change (Q3 TTM) - 18.58 % 7.64 % -2.25 %
Free Cash Flow 5 Year Avg. Change - 19.75 % 9.18 % 31.4 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - 291.63 % 309.14 % 413.41 %
Seq. Net Cash Flow Change (Q3 MRQ) - - -26.05 % 2294.6 %
Y / Y Net Cash Flow Change (Q3 TTM) - 47.61 % - -37.81 %
Seq. Net Cash Flow Change (Q3 TTM) - - 71.34 % -
Net Cash Flow 5 Year Avg. Change 204.02 % 16.74 % 61.01 % -

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) 59.54 % 164.65 % 31.15 % 0.08 %
Seq. Capital Expenditures Change (Q3 MRQ) - - 299.12 % 3.99 %
Y / Y Capital Expenditures Change (Q3 TTM) 10.91 % -8.99 % 0.43 % 2.24 %
Seq. Capital Expenditures Change (Q3 TTM) 55.09 % 10.93 % 9.43 % 2.65 %
Capital Expenditures 5 Year Avg. Change - 26.14 % 20.94 % 13.39 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 





             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ESE's Profile

Stock Price

ESE's Financials

Business Description

Fundamentals

Charts & Quotes

ESE's News

Suppliers

ESE's Competitors

Customers & Markets

Economic Indicators

ESE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071